Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOSS-Trial I: Optimization of Blood Pressure Management After Acute Ischemic Stroke
NCT03024476Phase 2Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Sep 2016
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olmesartan in hypertension (HTN), sponsored by Seoul National University Bundang Hospital. Started Sep 2016; status: completed.
02
Drugs
olmesartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT03024476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03024476.